DE69231536T2 - Verbindungen und methoden zur sublingualen oder buccalen verabreichung von therapeutischen agentien - Google Patents
Verbindungen und methoden zur sublingualen oder buccalen verabreichung von therapeutischen agentienInfo
- Publication number
- DE69231536T2 DE69231536T2 DE69231536T DE69231536T DE69231536T2 DE 69231536 T2 DE69231536 T2 DE 69231536T2 DE 69231536 T DE69231536 T DE 69231536T DE 69231536 T DE69231536 T DE 69231536T DE 69231536 T2 DE69231536 T2 DE 69231536T2
- Authority
- DE
- Germany
- Prior art keywords
- sublingual
- therapeutic agents
- buccal administration
- compounds
- methods
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Gastroenterology & Hepatology (AREA)
- Physiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nutrition Science (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US75084391A | 1991-08-26 | 1991-08-26 | |
PCT/US1992/006944 WO1993003751A1 (en) | 1991-08-26 | 1992-08-18 | Compositions and methods for the sublingual or buccal administration of therapeutic agents |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69231536D1 DE69231536D1 (de) | 2000-11-30 |
DE69231536T2 true DE69231536T2 (de) | 2001-06-13 |
Family
ID=25019382
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69231536T Expired - Fee Related DE69231536T2 (de) | 1991-08-26 | 1992-08-18 | Verbindungen und methoden zur sublingualen oder buccalen verabreichung von therapeutischen agentien |
Country Status (14)
Country | Link |
---|---|
US (1) | US5284657A (de) |
EP (1) | EP0601053B1 (de) |
JP (1) | JPH06510046A (de) |
KR (1) | KR100256715B1 (de) |
AT (1) | ATE197126T1 (de) |
AU (1) | AU669856B2 (de) |
CA (1) | CA2103163C (de) |
DE (1) | DE69231536T2 (de) |
DK (1) | DK0601053T3 (de) |
ES (1) | ES2153362T3 (de) |
GR (1) | GR3035116T3 (de) |
IL (1) | IL102857A (de) |
PT (1) | PT100812B (de) |
WO (1) | WO1993003751A1 (de) |
Families Citing this family (72)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5487898A (en) * | 1991-08-26 | 1996-01-30 | Abbott Laboratories | Compositions and method for the sublingual or buccal administration therapeutic agents |
US5567592A (en) * | 1994-02-02 | 1996-10-22 | Regents Of The University Of California | Screening method for the identification of bioenhancers through the inhibition of P-glycoprotein transport in the gut of a mammal |
WO1996039995A1 (en) * | 1995-06-07 | 1996-12-19 | Southern Biosystems, Inc. | High viscosity liquid controlled delivery system |
US5716928A (en) * | 1995-06-07 | 1998-02-10 | Avmax, Inc. | Use of essential oils to increase bioavailability of oral pharmaceutical compounds |
US5665386A (en) * | 1995-06-07 | 1997-09-09 | Avmax, Inc. | Use of essential oils to increase bioavailability of oral pharmaceutical compounds |
US7833543B2 (en) | 1995-06-07 | 2010-11-16 | Durect Corporation | High viscosity liquid controlled delivery system and medical or surgical device |
CA2224227A1 (en) * | 1995-06-07 | 1996-12-19 | Avmax, Inc. | Use of essential oils to increase bioavailability of oral pharmaceutical compounds |
WO1997011709A1 (en) * | 1995-09-25 | 1997-04-03 | Ashmont Holdings Limited | Anthelmintic macrocyclic lactone compositions |
US6949264B1 (en) | 1996-11-27 | 2005-09-27 | Wm. Wrigley Jr. Company | Nutraceuticals or nutritional supplements and method of making |
EP0880969A1 (de) * | 1997-05-28 | 1998-12-02 | Applied Research Systems ARS Holdings N.V. | Im physiologischem Medium schwerlösliche pharmazeutische Peptidezusammensetzungen |
EP1029536B1 (de) | 1997-10-01 | 2007-11-28 | Novadel Pharma Inc. | Nichtpolare Spray zur bukkalen Verabreichung |
US20040136914A1 (en) * | 1997-10-01 | 2004-07-15 | Dugger Harry A. | Buccal, polar and non-polar spray containing ondansetron |
US7632517B2 (en) | 1997-10-01 | 2009-12-15 | Novadel Pharma Inc. | Buccal, polar and non-polar spray containing zolpidem |
US20030095925A1 (en) * | 1997-10-01 | 2003-05-22 | Dugger Harry A. | Buccal, polar and non-polar spray or capsule containing drugs for treating metabolic disorders |
US6319913B1 (en) * | 1997-11-10 | 2001-11-20 | Cellegy Pharmaceuticals, Inc. | Penetration enhancing and irritation reducing systems |
AU2870899A (en) * | 1998-02-26 | 1999-09-15 | Abbott Laboratories | Oral formulation for hydrophilic drugs |
WO2000033866A1 (en) * | 1998-12-04 | 2000-06-15 | Provalis Uk Limited | Pharmaceutical compositions containing insulin |
US6586023B1 (en) | 1998-12-15 | 2003-07-01 | Wm. Wrigley Jr. Company | Process for controlling release of active agents from a chewing gum coating and product thereof |
US6627234B1 (en) | 1998-12-15 | 2003-09-30 | Wm. Wrigley Jr. Company | Method of producing active agent coated chewing gum products |
US7163705B2 (en) * | 1998-12-15 | 2007-01-16 | Wm. Wrigley Jr. Company | Coated chewing gum product and method of making |
US6531114B1 (en) | 1999-04-06 | 2003-03-11 | Wm. Wrigley Jr. Company | Sildenafil citrate chewing gum formulations and methods of using the same |
US6242473B1 (en) * | 1999-01-08 | 2001-06-05 | Maxim Pharmaceuticals, Inc. | Treatment and prevention of reactive oxygen metabolite-mediated cellular damage |
US6426090B1 (en) * | 1999-04-06 | 2002-07-30 | Wm. Wrigley Jr. Company | Over-coated product including tableted center and medicament |
US6773716B2 (en) | 1999-04-06 | 2004-08-10 | Wm. Wrigley Jr. Company | Over-coated chewing gum formulations |
US20020159956A1 (en) * | 1999-04-06 | 2002-10-31 | Ream Ronald L. | Over-coated chewing gum formulations |
US6322806B1 (en) * | 1999-04-06 | 2001-11-27 | Wm. Wrigley Jr. Company | Over-coated chewing gum formulations including tableted center |
US7935362B2 (en) * | 1999-04-06 | 2011-05-03 | Wm. Wrigley Jr. Company | Over-coated product including consumable center and medicament |
US6355265B1 (en) | 1999-04-06 | 2002-03-12 | Wm. Wrigley Jr. Company | Over-coated chewing gum formulations |
JP2003501404A (ja) | 1999-06-04 | 2003-01-14 | デルルックス ファーマシューティカル コーポレイション | 薬剤の脱水粒子からなる製剤およびこれの調製方法 |
US6541048B2 (en) | 1999-09-02 | 2003-04-01 | Wm. Wrigley Jr. Company | Coated chewing gum products containing an acid blocker and process of preparing |
US6569472B1 (en) | 2000-09-01 | 2003-05-27 | Wm. Wrigley Jr. Company | Coated chewing gum products containing antacid and method of making |
US6645535B2 (en) | 1999-09-02 | 2003-11-11 | Wm. Wrigley Jr. Company | Method of making coated chewing gum products containing various antacids |
US6663849B1 (en) | 2000-09-01 | 2003-12-16 | Wm. Wrigley Jr. Company | Antacid chewing gum products coated with high viscosity materials |
US9253991B2 (en) | 1999-09-20 | 2016-02-09 | Jack Barreca | Chewing gum with B vitamins |
WO2001021147A1 (en) * | 1999-09-20 | 2001-03-29 | Mastercare | Diet and weight control gum and sucker |
US9387168B2 (en) | 1999-09-20 | 2016-07-12 | Jack Barreca | Chewing gum with tomatidine |
US7115288B2 (en) * | 2000-06-09 | 2006-10-03 | Wm. Wrigley Jr. Company | Method for making coated chewing gum products with a coating including an aldehyde flavor and a dipeptide sweetener |
US6572900B1 (en) | 2000-06-09 | 2003-06-03 | Wm. Wrigley, Jr. Company | Method for making coated chewing gum products including a high-intensity sweetener |
US6444241B1 (en) | 2000-08-30 | 2002-09-03 | Wm. Wrigley Jr. Company | Caffeine coated chewing gum product and process of making |
US6579545B2 (en) | 2000-12-22 | 2003-06-17 | Wm. Wrigley Jr. Company | Coated chewing gum products containing an antigas agent |
KR20040058192A (ko) * | 2001-10-19 | 2004-07-03 | 맥심 파마수티컬즈 인크. | 간 질환 치료용으로서의 히스타민 용도 |
US20030215462A1 (en) * | 2001-12-21 | 2003-11-20 | Wacher Vincent J. | Use of UGT inhibitors to increase bioavailability |
US20040001889A1 (en) | 2002-06-25 | 2004-01-01 | Guohua Chen | Short duration depot formulations |
AU2003262804A1 (en) * | 2002-08-22 | 2004-03-11 | Nutrition 21, Inc. | Arginine silicate inositol complex and use thereof |
EP1575569B1 (de) | 2002-12-13 | 2010-09-29 | Durect Corporation | Orale darreichungsform mit flüssigen hochviskosen trägersystemen |
JP2006514962A (ja) * | 2003-01-30 | 2006-05-18 | カウンシル・オブ・サイエンティフィック・アンド・インダストリアル・リサーチ | キャラウェー抽出物及びその分画の活性を強化する生物学的利用能 |
WO2004087190A1 (en) * | 2003-04-02 | 2004-10-14 | Genix Therapeutics Inc. | Method for the treatment of prostate cancer |
DK1660039T3 (en) * | 2003-07-18 | 2017-01-16 | Oakwood Laboratories L L C | PREVENTION OF REDUCTION OF THE POLYMER MOLECULE WEIGHT, THE PREPARATION OF PURPOSES AND GELING IN POLYMER COMPOSITIONS |
JP4388322B2 (ja) * | 2003-07-31 | 2009-12-24 | 花王株式会社 | アポリポプロテインd分解抑制剤 |
US20050171192A1 (en) * | 2003-12-11 | 2005-08-04 | Gehlsen Kurt R. | Use of histamine to treat bone disease |
US8492106B2 (en) | 2004-05-24 | 2013-07-23 | Universitat Zu Koln | Identification methods for ergothioneine transporter modulators and therapeutic uses thereof |
US20060002913A1 (en) * | 2004-06-22 | 2006-01-05 | Gehlsen Kurt R | Use of histamine and related compounds to treat disorders affecting muscle function |
SI2767292T1 (sl) | 2004-09-17 | 2017-01-31 | Durect Corporation | Pripravek, ki vsebuje lokalni anestetik SAIB, s podaljšanim sproščanjem |
US8030271B2 (en) * | 2005-07-05 | 2011-10-04 | Emisphere Technologies, Inc. | Compositions and methods for buccal delivery of human growth hormone |
US8975227B2 (en) | 2005-07-15 | 2015-03-10 | Emisphere Technologies, Inc. | Intraoral dosage forms of glucagon |
US20070027105A1 (en) | 2005-07-26 | 2007-02-01 | Alza Corporation | Peroxide removal from drug delivery vehicle |
US20090054333A1 (en) * | 2006-10-17 | 2009-02-26 | Antonio Giordano | Peptide inhibitors of cyclin-dependent kinase activity and uses thereof |
DK2117521T3 (da) | 2006-11-03 | 2012-09-03 | Durect Corp | Transdermale indgivelsessystemer omfattende bupivacain |
US8415401B2 (en) | 2007-12-06 | 2013-04-09 | Durect Corporation | Oral pharmaceutical dosage forms |
US11963995B2 (en) | 2008-05-21 | 2024-04-23 | Ferring B.V. | Methods comprising desmopressin |
US20100286045A1 (en) | 2008-05-21 | 2010-11-11 | Bjarke Mirner Klein | Methods comprising desmopressin |
LT2712622T (lt) | 2008-05-21 | 2016-09-26 | Ferring B.V. | Burnoje disperguojamas desmopresinas, skirtas nikturijos netrikdomo miego pirminio periodo pailginimui |
US20100260844A1 (en) | 2008-11-03 | 2010-10-14 | Scicinski Jan J | Oral pharmaceutical dosage forms |
EP2498763A4 (de) | 2009-11-09 | 2015-10-07 | Spotlight Technology Partners Llc | Hydrogele auf polysaccharidbasis |
JP2013509963A (ja) | 2009-11-09 | 2013-03-21 | スポットライト テクノロジー パートナーズ エルエルシー | 断片化ヒドロゲル |
CN105120659A (zh) | 2013-03-15 | 2015-12-02 | 度瑞公司 | 用于降低溶解可变性的具有流变改性剂的组合物 |
US11191735B2 (en) | 2015-03-13 | 2021-12-07 | Nutrition 21, Llc | Arginine silicate for periodontal disease |
US20170135969A1 (en) | 2015-11-12 | 2017-05-18 | Jds Therapeutics, Llc | Topical arginine-silicate-inositol for wound healing |
EP3506895A4 (de) | 2016-09-01 | 2020-04-15 | JDS Therapeutics, LLC | Magnesiumbiotinatzusammensetzungen und verfahren zur verwendung |
WO2020092431A1 (en) | 2018-11-02 | 2020-05-07 | Nutrition 21, Llc | Compositions containing inositol-stabilized arginine silicate complexes and inositol for improving cognitive function in video gamers |
EP4076413A1 (de) | 2019-12-16 | 2022-10-26 | Nutrition 21, LLC | Verfahren zur herstellung von arginin-silikat-komplexen |
KR20220140711A (ko) | 2020-01-13 | 2022-10-18 | 듀렉트 코퍼레이션 | 불순물이 감소된 지속 방출 약물 전달 시스템 및 관련 방법 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4244946A (en) * | 1979-06-11 | 1981-01-13 | The Salk Institute For Biological Studies | Water-soluble peptides affecting gonadal function |
US4382922A (en) * | 1980-08-29 | 1983-05-10 | The Salk Institute For Biological Studies | Peptides affecting gonadal function |
US4632979A (en) * | 1984-06-18 | 1986-12-30 | Tulane Educational Fund | Therapeutic LHRH analogs |
US4801577A (en) * | 1987-02-05 | 1989-01-31 | Syntex (U.S.A.) Inc. | Nonapeptide and decapeptide analogs of LHRH useful as LHRH antagonists |
AU5157590A (en) * | 1989-02-06 | 1990-08-24 | Abbott Laboratories | Pharmaceutical compositions for oral administration |
-
1992
- 1992-08-18 DE DE69231536T patent/DE69231536T2/de not_active Expired - Fee Related
- 1992-08-18 ES ES92918805T patent/ES2153362T3/es not_active Expired - Lifetime
- 1992-08-18 AT AT92918805T patent/ATE197126T1/de not_active IP Right Cessation
- 1992-08-18 CA CA002103163A patent/CA2103163C/en not_active Expired - Fee Related
- 1992-08-18 WO PCT/US1992/006944 patent/WO1993003751A1/en active IP Right Grant
- 1992-08-18 JP JP5504536A patent/JPH06510046A/ja active Pending
- 1992-08-18 IL IL10285792A patent/IL102857A/xx not_active IP Right Cessation
- 1992-08-18 AU AU25193/92A patent/AU669856B2/en not_active Ceased
- 1992-08-18 EP EP92918805A patent/EP0601053B1/de not_active Expired - Lifetime
- 1992-08-18 KR KR1019930703608A patent/KR100256715B1/ko not_active IP Right Cessation
- 1992-08-18 DK DK92918805T patent/DK0601053T3/da active
- 1992-08-25 PT PT100812A patent/PT100812B/pt not_active IP Right Cessation
- 1992-11-30 US US07/983,111 patent/US5284657A/en not_active Expired - Fee Related
-
2000
- 2000-12-19 GR GR20000402804T patent/GR3035116T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
JPH06510046A (ja) | 1994-11-10 |
DK0601053T3 (da) | 2001-01-08 |
GR3035116T3 (en) | 2001-03-30 |
ATE197126T1 (de) | 2000-11-15 |
AU669856B2 (en) | 1996-06-27 |
IL102857A (en) | 1997-02-18 |
DE69231536D1 (de) | 2000-11-30 |
EP0601053B1 (de) | 2000-10-25 |
EP0601053A4 (en) | 1996-07-17 |
CA2103163A1 (en) | 1993-03-04 |
WO1993003751A1 (en) | 1993-03-04 |
CA2103163C (en) | 1998-10-20 |
KR100256715B1 (ko) | 2000-05-15 |
PT100812B (pt) | 1999-07-30 |
IL102857A0 (en) | 1993-01-31 |
AU2519392A (en) | 1993-03-16 |
US5284657A (en) | 1994-02-08 |
EP0601053A1 (de) | 1994-06-15 |
PT100812A (pt) | 1993-09-30 |
ES2153362T3 (es) | 2001-03-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE197126T1 (de) | Verbindungen und methoden zur sublingualen oder buccalen verabreichung von therapeutischen agentien | |
DE69425135T2 (de) | Substituierte cyclische carbonylderivate und analoga verwendbar als retrovirale proteasehemmer | |
FI883739A0 (fi) | Menetelmä terapeuttisesti aktiivisten fenoksi-indaanimetyyliamiinijohdannaisten valmistamiseksi | |
NO923142D0 (no) | Cykliske peptider og anvendelse derav | |
DE68913383D1 (de) | Rinderfaktor-Xa-hemmender Faktor und diesen enthaltende pharmazeutische Zusammensetzungen. | |
BR9708114A (pt) | Análogos xantona para o tratamento de doenças infecciosas. | |
ID18079A (id) | Komposisi farmasi yang mengandung bahan pemercepat osteogenesis | |
ATE215817T1 (de) | Feste miltefosin enthaltende arzneimittel zur oralen verabreichung bei der behandlung von leishmaniasis | |
ATE22530T1 (de) | Durch saeure stabilisierte mischungen von thienopyridinderivaten und verfahren zum verhindern der zersetzung solcher verbindungen. | |
DE3864210D1 (de) | Pharmazeutische dosierungseinheit zur vorbeugung bzw. behandlung von klimakterischen beschwerden. | |
ATE159512T1 (de) | Prozess zur herstellung von beta-phenylisoserin und analogen verbindungen | |
DE3686099T2 (de) | Analoga von cyclischen hexapeptiden von somatostatin, deren verfahren zur herstellung und sie enthaltende pharmazeutische zusammensetzungen. | |
DK598288A (da) | Vaeskeformig farmaceutisk sammensaetning til behandling af hoste og oemhed i halsen | |
DE69808475T2 (de) | Aminosäurederivate zur behandlung von schlaganfall | |
DE69301750T2 (de) | Verwendung von 1-Alpha,24(R)-Dihydroxy-22(E)-Dehydrovitamin-D3 zur Herstellung eines Arzneimittels zur Behandlung der Osteoporose | |
ATE114468T1 (de) | Ethyl-(+)-apovincaminat zur behandlung der demyelinisierung klinischer erscheinungen autoimmunen ursprungs. | |
EP0820771A3 (de) | Arzneimittel zur Behandlung von Neuropathien, das ein lipidlösliches Thiamin und eine Magnesiumverbindung enthält | |
DE3778826D1 (de) | Bestaendige therapeutische zusammensetzungen, basierend auf hydrophobem pflanzlichem oel und verfahren zu ihrer herstellung. | |
ATE145824T1 (de) | Aerosolformulierung enthaltend fusafungin | |
AR018532A1 (es) | Proteinas sustancialmente puras que contienen analogos de la beta-lipoproteina (blt); aislados de acidos nucleicos que codifican dichas proteinas yformulaciones farmaceuticas que comprenden las proteinas | |
NO922635D0 (no) | Ny anvendelse av benzimidazolin-2-okso-1-karboksylsyrederivater | |
ATE68345T1 (de) | Pharmazeutische zubereitung zur cholelitholyse. | |
DE69915852D1 (de) | Lhrh-analoga zur behandlung der osteoporose | |
AU628492B2 (en) | Improvements in chemical compounds | |
HUP9601528A2 (hu) | Véralvadásgátló hatású peptidszármazékok és a vegyületeket tartalmazó gyógyszerkészítmények |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |